Why Agilent Technologies Shares Are Rising Today

Agilent Technologies (A) is up 3.6% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be a positive read-through from stronger-than-expected results elsewhere in the life sciences tools group, which can lift sentiment for Agilent when investors see signs that lab and biopharma demand is improving. Agilent also entered this session with support from its own recent earnings beat and higher full-year outlook, so today’s move may reflect investors extending that more constructive view.

Details:

Agilent’s fiscal second-quarter 2026 results showed revenue of $1.83 billion, with reported growth of 10.0% and core growth of 6.3% year over year.

The company posted GAAP EPS of $1.20 in that quarter and raised its full-year 2026 guidance, giving investors a stronger baseline for the business.

Another major life sciences tools company reported better quarterly demand and lifted its outlook on July 23, which could be reinforcing the idea that sector conditions are improving.

Agilent also remained active in capital markets in late June, closing a $600 million senior notes offering that adds financial flexibility, though that does not look like the main cause of today’s jump.

Sources:

Agilent Technologies Investor Relations, SEC, Thermo Fisher Scientific Investor Relations

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive A Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$A Hedge Fund Activity

We have seen 460 institutional investors add shares of $A stock to their portfolio, and 493 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

GENERATION INVESTMENT MANAGEMENT LLP removed 4,180,266 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $476,466,718
AQR CAPITAL MANAGEMENT LLC added 1,623,527 shares (+118.7%) to their portfolio in Q1 2026, for an estimated $185,049,607
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,523,511 shares (-10.8%) from their portfolio in Q1 2026, for an estimated $173,649,783
CITADEL ADVISORS LLC added 1,243,015 shares (+222.5%) to their portfolio in Q1 2026, for an estimated $141,678,849
PICTET ASSET MANAGEMENT HOLDING SA removed 1,167,562 shares (-25.0%) from their portfolio in Q1 2026, for an estimated $133,078,716
JUPITER ASSET MANAGEMENT LTD added 1,124,313 shares (+225.3%) to their portfolio in Q1 2026, for an estimated $128,149,195
MACKENZIE FINANCIAL CORP removed 942,311 shares (-92.1%) from their portfolio in Q1 2026, for an estimated $107,404,607

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$A Government Contracts

We have seen $40,551,479 of award payments to $A over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

THE PURPOSE OF THIS CONTRACT IS TO PURCHASE AGILENT BULK RESOLUTION TECHNOLOGY (BRT) UNITS AND ASSOCIATED M...: $7,498,510
TO FURTHER DEVELOP AND PROCURE BULK RESOLUTION TECHNOLOGY (BRT) UNITS TO SUPPORT RESEARCH AND DEVELOPMENT (...: $2,387,640
GC/MS SYSTEM: $1,242,119
LIQUID CHROMATOGRAPHY TRIPLE QUADRUPOLE MASS SPECTROMETER (LCMS TRIPLE QUAD) AND A LIQUID CHROMATOGRAPHY WI...: $1,064,443
NEW PURCHASE, INSTRUMENTATION REQUIRED FOR LABORATORY ANALYSIS OF SYNTHETIC ORGANOFLUORINE CHEMICALS. THIS ...: $800,288

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

$A Price Targets

Multiple analysts have issued price targets for $A recently. We have seen 12 analysts offer price targets for $A in the last 6 months, with a median target of $155.0.

Here are some recent targets:

Vijay Kumar from Evercore ISI Group set a target price of $148.0 on 07/06/2026
Eve Burstein from Bernstein set a target price of $155.0 on 06/26/2026
Luke Sergott from Barclays set a target price of $150.0 on 06/24/2026
David Westenberg from Piper Sandler set a target price of $150.0 on 06/11/2026
Sidharth Sahoo from HSBC set a target price of $165.0 on 06/03/2026
Derik De Bruin from B of A Securities set a target price of $155.0 on 06/02/2026
Dan Leonard from RBC Capital set a target price of $155.0 on 05/28/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.